Lipe & Dalton Biogen Inc. Transaction History

Lipe & Dalton

$198 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$193.77 - $244.14 $1.94 Million - $2.44 Million	-10,005 Closed	0 $0
Q3 2021 Nov 01, 2021	SELL	$282.99 - $369.05 $19,809 - $25,833	-70 Reduced 0.69%	10,005 $2.83 Million
Q2 2021 Aug 02, 2021	SELL	$259.0 - $414.71 $738,150 - $1.18 Million	-2,850 Reduced 22.05%	10,075 $3.49 Million
Q1 2021 Apr 30, 2021	SELL	$242.95 - $284.63 $2,429 - $2,846	-10 Reduced 0.08%	12,925 $3.62 Million
Q4 2020 Jan 29, 2021	BUY	$236.26 - $355.63 $85,053 - $128,026	360 Added 2.86%	12,935 $3.17 Million
Q3 2020 Oct 30, 2020	BUY	$264.77 - $305.71 $274,036 - $316,409	1,035 Added 8.97%	12,575 $3.57 Million
Q2 2020 Aug 07, 2020	SELL	$258.66 - $342.55 $9,053 - $11,989	-35 Reduced 0.3%	11,540 $3.09 Million
Q1 2020 May 01, 2020	SELL	$268.85 - $341.04 $65,868 - $83,554	-245 Reduced 2.07%	11,575 $3.66 Million
Q4 2019 Jan 21, 2020	BUY	$220.06 - $304.07 $19,805 - $27,366	90 Added 0.77%	11,820 $3.51 Million
Q3 2019 Nov 07, 2019	SELL	$217.44 - $243.88 $61,752 - $69,261	-284 Reduced 2.36%	11,730 $2.73 Million
Q2 2019 Jul 24, 2019	BUY	$219.29 - $241.72 $1,096 - $1,208	5 Added 0.04%	12,014 $2.81 Million
Q1 2019 Apr 30, 2019	SELL	$216.71 - $338.96 $896,095 - $1.4 Million	-4,135 Reduced 25.61%	12,009 $2.84 Million
Q4 2018 Feb 08, 2019	SELL	$278.5 - $352.75 $38,990 - $49,385	-140 Reduced 0.86%	16,144 $4.86 Million
Q3 2018 Nov 05, 2018	BUY	$293.51 - $383.83 $42,558 - $55,655	145 Added 0.9%	16,284 $5.75 Million
Q2 2018 Aug 06, 2018	SELL	$257.52 - $306.91 $44,550 - $53,095	-173 Reduced 1.06%	16,139 $4.68 Million
Q1 2018 May 04, 2018	BUY	$260.13 - $367.91 $20,810 - $29,432	80 Added 0.49%	16,312 $4.47 Million
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $87,677 - $98,205	-285 Reduced 1.73%	16,232 $5.17 Million
Q3 2017 Nov 03, 2017	SELL	$281.15 - $329.69 $12,651 - $14,836	-45 Reduced 0.27%	16,517 $5.17 Million
Q2 2017 Aug 08, 2017	BUY	N/A	16,562	16,562 $4.49 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.44 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.39 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.13 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.08 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$752 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lipe & Dalton, based on Form 13F filings with the SEC.

News

Stay updated on Lipe & Dalton with notifications on news.

Account